Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05281159 · ClinicalTrials.gov registry record · NA
Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 20,509
- Enrollment target
NCT05281159: Completed NA study, sponsored by University of California, Los Angeles.
NCT05281159 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 20,509 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1362% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05281159, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 20,509 participants
- Enrollment target
Study Summary
In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A recommendations of continuing to screen average-risk adults ages 50-75 years old. As the investigators health system aims to screen the newly eligible population of average-risk patients between the ages of 45-49, the investigators proposed randomized controlled trial is aimed to determine the most effective patient outreach approach to increase patients' engagement with messages regarding CRC screening and screening uptake within this specific age-group.
Primary Outcome
Rate of clicking the link to MyChart within the SMS text message
Interventions
- BEHAVIORAL Risk Information
- BEHAVIORAL Risk Information + Action
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,509 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2022-11-21 |
| Phase | NA |
What the finished NCT05281159 record still lists
NCT05281159 is an interventional study that assigns participants to a tested intervention. Its 20,509 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1362% higher).
The record links to 0 conditions, and to 2 interventions - of which Risk Information is the first listed.
NCT05281159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05281159 about?
NCT05281159 is a clinical study titled "Increasing Engagement With Messages Regarding CRC Screening Among Adults Aged 45-49". In May of 2021, the United States Preventive Service Task Force (USPSTF) updated their colorectal cancer (CRC) screening guidelines by recommending screening at an earlier age for average-risk adults starting at the age of 45 years old (Grade B recommendation). This is in addition to their Grade A r...
What is the current status of trial NCT05281159?
This trial is currently completed. It is a NA study. The enrollment target is 20,509 participants. The study started on 2022-02-21. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT05281159?
The interventions under investigation include: Risk Information (BEHAVIORAL), Risk Information + Action (BEHAVIORAL).
Who is sponsoring clinical trial NCT05281159?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05281159's enrollment target sits among peer trials
20,509 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062342 · 20,400 participants · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI